Australian researchers warn GLP-1 weight-loss drugs may cause scurvy, the historic "pirate disease," due to poor nutrition ...

Feb 12 (Reuters) - Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a ...

TUPELO – Usage of GLP-1 drugs isn't new – they gained FDA approval in 2005, and evolved from 1980s diabetes research. But ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

And last month, Serena said that her life has changed “for the better” since she started using the medication, noting that it ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...

Sen. Tom Cotton, R-Ark., warned that up to 1.5 million Americans may be using weight loss medications with potentially dangerous Chinese ingredients.

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...